China Market Unsettled, But Novo Nordisk's Oral Wegovy May Keep Revenue On Track

Today, Novo Nordisk A/S ( NVO ) has launched a pill version of Wegovy in the U.S., the news that many investors were waiting for. They’re now offering a 30-day supply at just $149 forI hold a Master’s degree in Cell Biology and began my career working for several years as a lab technician in a drug discovery clinic, where I gained extensive hands-on experience in cell culture, assay development, and therapeutic research. That scientific foundation gave me an appreciation for the rigor and challenges behind ...

China Market Unsettled, But Novo Nordisk's Oral Wegovy May Keep Revenue On Track - Reportify